The group focuses its research on genetic epidemiology, molecular diagnosis of cancer, prognostic markers, prediction of therapeutic response and identification of new therapeutic targets. In addition, they provide comprehensive assistance to oncology patients from a multidisciplinary approach (assessment, treatment, evolution, follow-up).
The team’s projects of interest include IMAGene (https://www.imagene.ieo.eu/), which aims to identify biomarkers for the follow-up of people at high risk of pancreatic cancer, and MicroPanc, which seeks to evaluate the role of the microbiome in pancreatic cancer. Also the development of predictive models based on artificial intelligence techniques to predict oncological outcomes.